Skip to main content
Equibles
MYO logo

MYO · Myomo, Inc.

Track MYO — free

Use MYO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about MYO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.72 +0.26 (+17.81%) At close · Aug 14
Market Cap
$68.13M
Shares
39.61M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.72 Open$1.44 Day$1.42–1.77 52W close$0.64–1.72 Avg vol 30d515K Short int1.8M · 4.7% float · 5.6d Short vol30% Last earningsAug 5, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 5

Raw chart and full-history price indicators begin at the captured split on Jan 31, 2020; bars on opposite sides are not compared.

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +83%
      above
      Price vs 50-day avg +46%
      above
      RSI (14) 75
      overbought
      MACD trend Positive
      52-week position 100%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +81%
      trailing
      6-month return +149%
      trailing
      YTD return +89%
      this year
      Relative strength +135%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 50d above 200d
      Institutional flow Distributing
      -5% holders QoQ · +21 funds added
      Insider flow Accumulating
      Net +$43.4K over 90 days · 50% sells
      Short interest Falling
      4.66% of float · ▼ -23.4% MoM · 5.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      78 holders — mid 3-yr range
      Squeeze score 74
      high risk · 0–100
      Fundamentals
      Weak
      Revenue growth +40815%
      Y/Y
      Gross margin 3%
      contracting
      EPS growth −131%
      Y/Y
      Free cash flow $-16.3M
      Balance sheet $13.2M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 94%
      annualized · 1-yr
      Max drawdown −46%
      past year
      ATR 8.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 1 of last 2
      Latest guidance · from the 8-K filed Aug 5, 2026
      Revenue · third quarter 2026 $11.5M – $12M
      Prior guidance period ended · from the 8-K filed May 7, 2026
      Revenue · second quarter 2026 $10.3M – $10.8M
      Guided vs delivered · last 2 settled
      Revenue full year 2025
      guided $40M – $42M
      $40.93M In line
      Revenues first quarter 2024
      guided $4.1M – $4.3M
      $3.75M Miss −10.6%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +83% Bullish
      Price vs 50-day avg
      +46% Bullish
      RSI (14)
      75 Bearish
      MACD trend
      Positive Bullish
      52-week position
      100% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 50d above 200d
      Institutional flow Distributing
      -5% holders QoQ · +21 funds added
      Insider flow Accumulating
      Net +$43.4K over 90 days · 50% sells
      Short interest Falling
      4.66% of float · ▼ -23.4% MoM · 5.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      78 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $1 Now $2 · 100% Range high $2
      vs 200-day avg +83% vs 50-day avg +46%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      covered lives (in-network access) 100M second quarter of 2026 —
      MyoPro units 211 the quarter —
      Backlog 226 as of March 31, 2026 —
      MyoPro revenue units 172 Q1 2026 —
      MyoPro units (revenue units) 208 the fourth quarter —
      New candidates added to the patient pipeline 676 Q4 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      MYO
      Myomo, Inc.
      this stock
      		$68.13M +89.0% +56.8% — 4.7%
      ABT
      Abbott Laboratories
      		 $193.78B -11.2% +5.7% 31.2 1.3%
      SYK
      Stryker Corp
      		 $130.11B -3.5% +11.2% 35.2 2.2%
      MDT
      Medtronic plc
      		 $116.83B -5.0% +8.4% 24.5 1.4%
      BSX
      Boston Scientific Corp
      		 $75.11B -45.6% +12.5% 21.0 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      78
      % held
      29.2%
      Net QoQ
      -1.3M sh
      Top holder
      Rosalind Advisors, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      54
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      1.8M
      Days to cover
      5.6d
      Change
      -562.9K sh
      View
      Short Volume
      Short vol %
      30%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2
      Value
      $2
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      52.4%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$43.4K
      Buyers / Sellers
      1 / 1
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $40.9M
      Net income (FY)
      $-15.6M
      EPS diluted
      $-0.37
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 5, 2026
      This year
      13
      View
      Proposed Sales
      Value
      $5.6K
      Shares
      5.2K
      Filed
      Jul 13, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 5, 2026
      View

      Performance

      Raw-price comparisons begin at the captured split on Jan 31, 2020; windows that need an earlier baseline remain unavailable.

      5D 20D 120D MTD YTD
      MYO +21.1% +81.1% +148.9% +70.3% +89.0%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +20.7% +76.6% +135.1% +66.4% +75.2%
      Key facts CIK 1369290 CUSIP 62857J201 13F (30d) 75 filings 73 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)